CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Deficit	Retained Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2018			30,512,843
Beginning balance at Dec. 31, 2018	$ 109,596	$ (72)	$ 318	$ (10,245)	$ 243,007	$ (76,013)	$ (72)	$ (47,471)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			418,553
Issuance of restricted stock	5		$ 5
Surrender of common stock by employees (in shares)			(130,141)
Surrender of common stock by employees	(985)			(985)
Share-based compensation expense	2,845				2,845
Total comprehensive income (loss)	17,299					15,778		1,521
Ending balance (in shares) at Dec. 31, 2019			30,801,255
Ending balance at Dec. 31, 2019	128,688		$ 323	(11,230)	245,852	(60,307)		(45,950)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			544,787
Issuance of restricted stock	(10)		$ (10)
Surrender of common stock by employees (in shares)			(96,231)
Surrender of common stock by employees	(663)			(663)
Share-based compensation expense	3,460				3,460
Total comprehensive income (loss)	$ (36,105)					(37,049)		944
Ending balance (in shares) at Dec. 31, 2020	31,249,811		31,249,811
Ending balance at Dec. 31, 2020	$ 95,370		$ 313	(11,893)	249,312	(97,356)		(45,006)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			933,139
Issuance of restricted stock	8		$ 8
Surrender of common stock by employees (in shares)			(148,358)
Surrender of common stock by employees	(1,279)			(1,279)
Share-based compensation expense	6,254				6,254
Total comprehensive income (loss)	$ 26,300					23,732		2,568
Ending balance (in shares) at Dec. 31, 2021	32,034,592		32,034,592
Ending balance at Dec. 31, 2021	$ 126,653		$ 321	$ (13,172)	$ 255,566	$ (73,624)		$ (42,438)